Oral surgery patients are at considerable risk from intraoperative and postoperative bleeding, which, if unchecked, could have serious negative outcomes. The dentist should be knowledgeable about the many hemostatic medications available and how to use them during various bleeding episodes. Both healthy and systemically compromised people can experience bleeding problems. The physician will be able to apply a particular method when they are appropriate if they have a thorough understanding of the various management techniques. Sadly, due to a lack of knowledge about the coagulation process, as well as the approaches and materials that are accessible, some of the most effective management techniques and preventive measures, are not used. This article's goal is to evaluate the research on the uses of several local hemostatic agents in the control of bleeding during oral surgery, as well as the mechanisms underlying these agents' actions and potential drawbacks. The discussion also includes innovative hemostatic substances like Quikclot and emCon dental dressing. Patients with inherited and acquired bleeding disorders, as well as those who are taking antithrombotic drugs for systemic illnesses, can benefit greatly from local hemostatic agents in reducing bleeding during oral surgical operations.